PT-141

Volume Pricing

Research Overview

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and melanocortin-receptor agonist derived from Melanotan II. It is a referenced compound in neuroendocrine and behavioral research.

Preclinical and clinical research has examined PT-141 across centrally-mediated arousal pathways and melanocortin-receptor signaling, making it a distinct subject within melanocortin-research models.

Research Focus

Mechanism (Research Context)

PT-141 is studied for its agonism at the MC4R melanocortin receptor in the central nervous system, where it is observed to influence arousal and behavioral pathways independently of the vascular system in research models.

Intended Use

This compound is strictly intended for in vitro laboratory research. It is not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics.

Legal Disclaimer

This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Usage is restricted to certified laboratories and qualified research professionals.

Terms of Sale

All sales by Codex Research are final. Buyers must be qualified professionals and assume full responsibility for safe handling and regulatory compliance. Every batch is independently verified by accredited third-party laboratories. Batch-specific Certificates of Analysis are available on our COAs page.